Evidence map›Paper›PMID 38237091›Full record

ArticleChronic obstructive pulmonary diseases (Miami, Fla.)2024

The Neutrophil-to-Lymphocyte Ratio as a Predictor of Acute Exacerbations Among Patients With COPD in Uganda.

Patricia Alupo, Winceslaus Katagira, David Mukunya, Paul Okimat, Vickram Tejwani, Alex Kayongo, Joanitah Nalunjogi, Nicole M Robertson, Rupert Jones, John R Hurst and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Chronic obstructive pulmonary diseases (Miami, Fla.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 3 countries.

Patricia AlupoMakerere University Lung Institute, Kampala, Uganda.
Winceslaus KatagiraMakerere University Lung Institute, Kampala, Uganda.
David MukunyaDepartment of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Paul OkimatSoroti District Local Government, Soroti, Uganda.
Vickram TejwaniRespiratory Institute, Cleveland Clinic, Cleveland, Ohio, United States.
Alex KayongoMakerere University Lung Institute, Kampala, Uganda.
Joanitah NalunjogiMakerere University Lung Institute, Kampala, Uganda.
Nicole M RobertsonDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States.
Rupert JonesMakerere University Lung Institute, Kampala, Uganda.
John R HurstUCL Respiratory, University College London, London, United Kingdom.
Bruce KirengaMakerere University Lung Institute, Kampala, Uganda.
Trishul SiddharthanDivision of Pulmonary, Critical Care and Sleep Medicine, University of Miami, Miami, Florida, United States.
Makerere University · UGCleveland Clinic · USJohns Hopkins University · USSoroti Hospital · UGUniversity College London · GBUniversity of Miami · US

Funding

Training in noncommunicable diseases epidemiological, data science and Implementation Science research to strengthen evidence-based interventions, policy and control in Uganda.D43TW011401 · FIC · MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES · PI Charles Batte, William Checkley · 2019 to 2026
$1.8M
Investigating the role of altered lung microbiome in fueling Th17 mediated airway inflammation in COPD among HIV-infected individualR21TW012354 · FIC · MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES · PI KAYONGO, ALEX · 2022 to 2023
$573k
FIC NIH HHS D43 TW011401FIC NIH HHS R21 TW012354
6 · The paper itself

Abstract

Background: The neutrophil-to-lymphocyte ratio (NLR) is an inexpensive biomarker that potentially predicts acute exacerbations of chronic obstructive pulmonary disease (AECOPDs). We evaluated the association of baseline NLR and respiratory hospitalization risk within one year among chronic obstructive pulmonary disease (COPD) patients in Uganda, a low- and middle-income country. Methods: A total of 312 COPD patients were followed for one year. Clinical characteristics and exacerbation rates were collected. Poisson regression with robust variance estimators was used to measure the association between NLR and hospital admissions due to COPD exacerbations. Receiver-operator characteristic (ROC) curves and the area under the curve were used to assess the ability of NLR to predict AECOPDs. Results: The median (Q 1, Q 3) age was 64 years (53, 71). Females comprised 50.96% (n=159) of the cohort, and 71.2% (n=222) of participants had moderate or severe COPD. A total of 9.9% (n=31) of participants experienced a COPD exacerbation during the period of follow-up. At baseline, the median (Q 1, Q 3) NLR ratio among participants who experienced an exacerbation was 1.46 (0.92, 2.33) compared to 1.03 (0.72,1.42) among those who did not experience one during the follow-up period ( Conclusion: The NLR could be used as a risk predictor, in low- and middle-income countries, for hospital admissions due to COPD exacerbations. A cutoff of 1.17 was an independent predictor of hospitalization due to acute exacerbations of COPD within one year.

Indexed as

acute exacerbations of COPDbiomarkersCOPDexacerbationsneutrophil lymphocyte ratio

Identifiers

PMID38237091
PMCPMC11075344
OpenAlexW4390969705

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.